CVR: 42523925
DKK -3,390,139
Gross profit
Net result: DKK -5,039,754
Kristian Helin, Hannibal Innovation ApS
1 more
CVR · view ownership and management
Director registered: Karin Absalonsen
CVR · 01/05/2026
View the full event history
Dania Therapeutics ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Karin Absalonsen. The company is owned by Kristian Helin, Hannibal Innovation ApS and Vernalis (R&D) Limited. In 2025, the company reported a gross profit of DKK -3,390,139 and a net result of DKK -5,039,754 compared with DKK -9,556,855 the year before. Equity in the 2025 report amounted to DKK -15,413,086.
Selskabets formål er at drive forsknings- og udviklingsvirksomhed inden for bioteknologi med henblik på udvikling og kommercialisering af lægemidler inden for cancer samt anden i forbindelse hermed stående virksomhed
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorDania Therapeutics ApS was founded on 1 July 2021.
Dania Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Dania Therapeutics ApS is owned by Kristian Helin, Hannibal Innovation ApS and Vernalis (R&D) Limited.
In 2025, Dania Therapeutics ApS reported a gross profit of DKK -3,390,139.
The management of Dania Therapeutics ApS consists of Karin Absalonsen.
Dania Therapeutics ApS is located at c/o Nyborg & Rørdam Advokatfirma P/S, Store Kongensgade 77, 1264 København K.
Claim this page to add your logo and social links. Free to get started.
Dania Therapeutics ApS has published its annual report for 2025. Revenue came to DKK 0, and the net result was DKK -5,039,754.
As of May 1, 2026, Karin Absalonsen is registered as director of Dania Therapeutics ApS.
As of May 1, 2026, Hamed Mozaffari Brodersen has stepped down as director of Dania Therapeutics ApS.
Dania Therapeutics ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -9,556,855.
Dania Therapeutics ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -8,721,963.
As of January 15, 2024, Kristian Helin has joined the board of directors of Dania Therapeutics ApS.
As of January 15, 2024, Kim Andersen has left the board of directors of Dania Therapeutics ApS.
As of November 1, 2023, Michael Manchuan Li has joined the board of directors of Dania Therapeutics ApS.
As of November 1, 2023, Lars Michael Wood has left the board of directors of Dania Therapeutics ApS.
Dania Therapeutics ApS has published its interim report for the period July 1, 2021 – December 31, 2022.
As of December 14, 2022, Hannibal Innovation ApS is registered as an owner of Dania Therapeutics ApS with an ownership share of 15%.
As of December 14, 2022, is registered as an owner of Dania Therapeutics ApS with an ownership share of 25%.
As of August 26, 2022, Kristian Helin is registered as an owner of Dania Therapeutics ApS with an ownership share of 33%.
As of October 18, 2021, Kim Andersen has joined the board of directors of Dania Therapeutics ApS.
As of October 18, 2021, Lars Michael Wood has joined the board of directors of Dania Therapeutics ApS.
As of October 18, 2021, Kristian Helin has left the board of directors of Dania Therapeutics ApS.
As of July 1, 2021, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Dania Therapeutics ApS.
As of July 1, 2021, Karin Absalonsen has joined the board of directors of Dania Therapeutics ApS.
As of July 1, 2021, Kristian Helin has joined the board of directors of Dania Therapeutics ApS.
As of July 1, 2021, Hamed Mozaffari Brodersen is registered as director of Dania Therapeutics ApS.
Dania Therapeutics ApS was founded on July 1, 2021.
Companies in the same industry and area
CVR 29418888
CVR 29769796
CVR 34688605
CVR 34892970
CVR 35047565
